ELCO Management Co., LLC
Position in SLS — SELLAS Life Sciences Group, Inc.
CIK 1690717
New York, NY
Position in SLS
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$61,796
+$6,721 QoQ
Shares Held
14,609
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ELCO Management Co., LLC holds $94,186 across 2 Biotechnology names. SLS ranks #1 (65.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLS |
SELLAS Life Sciences Group, Inc.
This page
|
14,609 | $61,796 | |
| 2 | LCTX |
Lineage Cell Therapeutics, Inc.
|
20,500 | $32,390 |
All Filings in SLS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,796 | 14,609 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $55,075 | 14,609 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $22,554 | 14,009 | Shares | Sole | 2025-11-05 | |
| No filing history on record for this holder in this stock. | ||||||